HK1105202A1 - Heterocyclic compound and anti-malignant-tumor agent containing the same as active ingredient - Google Patents

Heterocyclic compound and anti-malignant-tumor agent containing the same as active ingredient

Info

Publication number
HK1105202A1
HK1105202A1 HK07110520.1A HK07110520A HK1105202A1 HK 1105202 A1 HK1105202 A1 HK 1105202A1 HK 07110520 A HK07110520 A HK 07110520A HK 1105202 A1 HK1105202 A1 HK 1105202A1
Authority
HK
Hong Kong
Prior art keywords
malignant
active ingredient
same
agent containing
heterocyclic compound
Prior art date
Application number
HK07110520.1A
Other languages
English (en)
Inventor
Seiichiro Kawashima
Toshiyuki Matsuno
Shinichi Yaguchi
Yoshio Tsuchida
Kenichi Saitoh
Tetsuo Watanabe
Original Assignee
Zenyaku Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zenyaku Kogyo Kk filed Critical Zenyaku Kogyo Kk
Publication of HK1105202A1 publication Critical patent/HK1105202A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK07110520.1A 2004-03-31 2007-09-27 Heterocyclic compound and anti-malignant-tumor agent containing the same as active ingredient HK1105202A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004103273 2004-03-31
PCT/JP2005/006111 WO2005095389A1 (ja) 2004-03-31 2005-03-30 複素環式化合物及びそれを有効成分とする抗悪性腫瘍剤

Publications (1)

Publication Number Publication Date
HK1105202A1 true HK1105202A1 (en) 2008-02-06

Family

ID=35063701

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07110520.1A HK1105202A1 (en) 2004-03-31 2007-09-27 Heterocyclic compound and anti-malignant-tumor agent containing the same as active ingredient

Country Status (11)

Country Link
US (1) US7855199B2 (xx)
EP (1) EP1741714B1 (xx)
JP (1) JP4733021B2 (xx)
KR (1) KR101130913B1 (xx)
CN (1) CN100532380C (xx)
AU (1) AU2005227954B2 (xx)
CA (1) CA2561406C (xx)
DK (1) DK1741714T3 (xx)
ES (1) ES2400056T3 (xx)
HK (1) HK1105202A1 (xx)
WO (1) WO2005095389A1 (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002088112A1 (fr) 2001-04-27 2002-11-07 Zenyaku Kogyo Kabushiki Kaisha Compose heterocyclique et agent antitumoral contenant ce dernier en tant qu'ingredient actif
AU2006221285B2 (en) 2005-03-11 2011-03-31 Zenyaku Kogyo Kabushikikaisha Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
WO2008032077A1 (en) * 2006-09-14 2008-03-20 Astrazeneca Ab Pyrimidine derivatives
WO2009066775A1 (ja) 2007-11-22 2009-05-28 Zenyaku Kogyo Kabushikikaisha 複素環式化合物の非晶質体、それを含む固体分散体、薬剤、およびその製造法
JP2011515462A (ja) * 2008-03-27 2011-05-19 アウククランド ウニセルビセス リミテッド 置換されたピリミジン、及びトリアジン、並びに癌療法におけるこれらの使用
CA2755935A1 (en) 2009-02-12 2010-08-19 Astellas Pharma Inc. Hetero ring derivative
EP2411387B1 (en) 2009-03-27 2015-08-19 VetDC, Inc. Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
EP3072890B1 (en) 2009-07-07 2018-10-17 MEI Pharma, Inc. Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy
WO2012020762A1 (ja) * 2010-08-10 2012-02-16 アステラス製薬株式会社 へテロ環化合物
WO2012044641A1 (en) * 2010-09-29 2012-04-05 Pathway Therapeutics Inc. 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
RU2608742C2 (ru) 2011-03-28 2017-01-23 ЭмИАй ФАРМА, ИНК. (альфа-замещенные аралкиламино- и гетероарилалкиламино)пиримидинил- и 1, 3, 5-триазинилбензимидазолы, их фармацевтические композиции и их применение в лечении пролиферативных заболеваний
CN105175410B (zh) * 2015-10-14 2018-01-05 湖南华腾制药有限公司 三嗪类化合物及其制备方法和抗肿瘤应用
WO2018217787A1 (en) 2017-05-23 2018-11-29 Mei Pharma, Inc. Combination therapy
EP3668507A4 (en) 2017-08-14 2021-05-12 MEI Pharma, Inc. COMBINATION THERAPY

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW312694B (xx) * 1994-09-26 1997-08-11 Daiichi Seiyaku Co
CN1129597C (zh) * 1997-07-24 2003-12-03 全药工业株式会社 杂环化合物和以其为有效成分的抗肿瘤剂
WO2002088112A1 (fr) * 2001-04-27 2002-11-07 Zenyaku Kogyo Kabushiki Kaisha Compose heterocyclique et agent antitumoral contenant ce dernier en tant qu'ingredient actif
AU2003272972A1 (en) * 2002-10-11 2004-05-04 Kowa Co., Ltd. Method of treatment for cancer
EP1557415B1 (en) * 2002-10-25 2012-06-06 Zenyaku Kogyo Kabushikikaisha Heterocyclic compounds and antitumor drugs containing the same as the active ingredient

Also Published As

Publication number Publication date
EP1741714A1 (en) 2007-01-10
KR20070008670A (ko) 2007-01-17
CA2561406A1 (en) 2005-10-13
JPWO2005095389A1 (ja) 2008-02-21
AU2005227954B2 (en) 2011-02-10
AU2005227954A1 (en) 2005-10-13
EP1741714B1 (en) 2013-01-09
CN1972935A (zh) 2007-05-30
US20080287431A1 (en) 2008-11-20
JP4733021B2 (ja) 2011-07-27
KR101130913B1 (ko) 2012-03-28
US7855199B2 (en) 2010-12-21
CN100532380C (zh) 2009-08-26
DK1741714T3 (da) 2013-04-15
ES2400056T3 (es) 2013-04-05
EP1741714A4 (en) 2007-09-12
CA2561406C (en) 2012-07-03
WO2005095389A1 (ja) 2005-10-13

Similar Documents

Publication Publication Date Title
HK1105202A1 (en) Heterocyclic compound and anti-malignant-tumor agent containing the same as active ingredient
HK1118016A1 (en) Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
IL170690A0 (en) Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
IL181783A0 (en) Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient
EP1932833A4 (en) NITROGENATED HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF
IL178297A0 (en) Hydrazide derivatives and pharmaceutical compositions containing the same
IL179837A0 (en) Cyclic and heterocyclic compounds having anti-bacterial activity and pharmaceutical compositions containing the same
IL174128A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
IL191141A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
IL186665A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
IL187434A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
ZA200702684B (en) 3-triazolylphenyl sulfide derivative and insecticide/ acaricide/nematicide containing the same as active ingredient
PL372084A1 (en) 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
EP1970377A4 (en) LINCOMYCIN DERIVATIVE AND ANTIBACTERIAL AGENT CONTAINING THIS AS AN ACTIVE SUBSTANCE
HK1086830A1 (en) Heterocyclic compounds and antitumor drugs containing the same as the active ingredient
EP1780202A4 (en) QUINOLINE DERIVATIVE AND INSECTICIDE CONTAINING CELLUI-CI AS ACTIVE INGREDIENT
IL192184A0 (en) Heterocyclic derivatives and pharmaceutical compositions containing the same
PL1937664T3 (pl) Związki hydrazydowe i ich zastosowanie jako pestycydy
ZA200807767B (en) Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
IL192298A (en) Heterocyclic Compounds, Their Acceptable Salts, Pharmaceuticals Containing and Using Them
IL175359A0 (en) Herbicidally active agent
IL190506A0 (en) Amide derivatives and pesticidal compositions containing the same
IL182664A0 (en) Triazole derivatives and pharmaceutical compositions containing the same
IL164699A0 (en) Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
IL174249A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170330